Form 8-K - Current report:
SEC Accession No. 0001104659-24-087596
Filing Date
2024-08-09
Accepted
2024-08-09 09:04:35
Documents
16
Period of Report
2024-08-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2421213d1_8k.htm   iXBRL 8-K 29302
2 EXHIBIT 1.1 tm2421213d1_ex1-1.htm EX-1.1 207466
3 EXHIBIT 5.1 tm2421213d1_ex5-1.htm EX-5.1 10297
7 GRAPHIC tm2421213d1_ex5-1img001.jpg GRAPHIC 8901
  Complete submission text file 0001104659-24-087596.txt   492539

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pgen-20240807.xsd EX-101.SCH 3015
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pgen-20240807_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pgen-20240807_pre.xml EX-101.PRE 22359
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2421213d1_8k_htm.xml XML 3551
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36042 | Film No.: 241190566
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)